GINS1
DNA replication complex GINS protein PSF1
Also known as: KIAA0186, PSF1, PSF1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q14691
- Gene
- GINS1
- Ensembl
- ENSG00000101003
- Chromosome
- 20
- Canonical length
- 196 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
The yeast heterotetrameric GINS complex is made up of Sld5 (GINS4; MIM 610611), Psf1, Psf2 (GINS2; MIM 610609), and Psf3 (GINS3; MIM 610610). The formation of the GINS complex is essential for the initiation of DNA replication in yeast and Xenopus egg extracts (Ueno et al., 2005 [PubMed 16287864]).[supplied by OMIM, Mar 2008]
Canonical amino-acid sequenceUniProt
196 residues, UniProt reviewed canonical sequence.
>Q14691|GINS1
1 MFCEKAMELI RELHRAPEGQ LPAFNEDGLR QVLEEMKALY EQNQSDVNEA KSGGRSDLIP
61 TIKFRHCSLL RNRRCTVAYL YDRLLRIRAL RWEYGSVLPN ALRFHMAAEE MEWFNNYKRS
121 LATYMRSLGG DEGLDITQDM KPPKSLYIEV RCLKDYGEFE VDDGTSVLLK KNSQHFLPRW
181 KCEQLIRQGV LEHILSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GINS1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.33
- Highest tissue expression
- 8.3 nTPM
Expression across tissuesHPA
Tissue
- testis: 8.3 nTPM
- thymus: 6.8 nTPM
- tonsil: 5.4 nTPM
- lymph node: 4.8 nTPM
- esophagus: 4 nTPM
- bone marrow: 3.7 nTPM
Single-cell type
- early spermatids: 101 nCPM
- late primary spermatocytes: 74 nCPM
- early primary spermatocytes: 66 nCPM
- erythrocyte progenitors: 56 nCPM
- differentiating spermatogonia: 52 nCPM
- megakaryocyte progenitors: 49 nCPM
Immune cell
- T-reg: 1 nTPM
- memory B-cell: 0.8 nTPM
- myeloid DC: 0.5 nTPM
- naive B-cell: 0.5 nTPM
- plasmacytoid DC: 0.5 nTPM
- NK-cell: 0.4 nTPM
Brain region
- cerebellum: 5.3 nTPM
- white matter: 4.8 nTPM
- thalamus: 4.4 nTPM
- cerebral cortex: 4.3 nTPM
- pons: 4.2 nTPM
- basal ganglia: 4.1 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about GINS1.
Disease | AllUniProt
Conditions GINS1 is implicated in, by any mechanism.
- Immunodeficiency 55 (IMD55) MIM:617827
Disease | GeneticClinVar
2 pathogenic / likely-pathogenic of 204 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Combined immunodeficiency due to GINS1 deficiency
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.28
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.22
- DepMap mean gene effect
- -2.02
- DepMap dependency class
- pan
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 10% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- DNA replication
- inner cell mass cell proliferation
- DNA strand elongation involved in mitotic DNA replication
Cellular components
Protein domainsUniProt · Pfam · InterPro
- GINS subunit, domain A
- GINS, helical bundle-like domain superfamily
- GINS complex protein helical bundle domain
- GINS complex, subunit Psf1
- DNA replication complex GINS protein PSF1, C-terminal domain
- PSF1 C-terminal domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of GINS1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GINS1 as an antibody target. Whether an autoantibody or antibody against GINS1 could matter depends on whether native GINS1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GINS1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label GINS1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...